Fineline Cube

Follow:
14499 Articles
Salubris Pharma's Xinchaotuo Gains NMPA Approval for Primary Hypertension
CompanyDrug

Salubris Pharma’s Xinchaotuo Gains NMPA Approval for Primary Hypertension

Nhwa Pharmaceutical Jiangsu Haoxinqing Overseas Listing
CompanyDeals

Jiangsu Nhwa’s Investee Jiangsu Haoxinqing Plans Overseas Listing

Shenyang Xingqi Pharmaceuticals Plans Private Placement to Fund R&D Center
CompanyDeals

Shenyang Xingqi Pharmaceuticals Plans Private Placement to Fund R&D Center

Novartis' Beovu Approved by NMPA for Diabetic Macular Edema Treatment
CompanyDrug

Novartis’ Beovu Approved by NMPA for Diabetic Macular Edema Treatment

Mabworks' MIL62 Gains NMPA Review for NMOSD Treatment
CompanyDrug

Mabworks’ MIL62 Gains NMPA Review for NMOSD Treatment

EpimAb Biotherapeutics and Juri Biosciences Ink Global Licensing Deal for KLK2-CD3 T-Cell Engager
CompanyDeals

EpimAb Biotherapeutics and Juri Biosciences Ink Global Licensing Deal for KLK2-CD3 T-Cell Engager

Eli Lilly to Acquire SiteOne Therapeutics for Up to USD 1 Billion
CompanyDeals

Eli Lilly to Acquire SiteOne Therapeutics for Up to USD 1 Billion

Junshi Biosciences' Junshida Wins NMPA Approval for HeFH and Statin-Intolerant Patients
CompanyDrug

Junshi Biosciences’ Junshida Wins NMPA Approval for HeFH and Statin-Intolerant Patients

Sino Biopharmaceutical Presents TQB2102 Phase I Results at ASCO 2025
CompanyDrug

Sino Biopharmaceutical Presents TQB2102 Phase I Results at ASCO 2025

BeiGene Rebrands to BeOne Medicines and Relocates to Switzerland
Company

BeiGene Rebrands to BeOne Medicines and Relocates to Switzerland

Betta Pharmaceuticals Partners with BioRay for Herceptin Biosimilar Anruize
CompanyDeals

Betta Pharmaceuticals Partners with BioRay for Herceptin Biosimilar Anruize

China's NMPA Approves Lifetech's Aortic Fenestration Stent System
CompanyMedical Device

China’s NMPA Approves Lifetech’s Aortic Fenestration Stent System